About Cell Microsystems
Cell Microsystems is a company based in Durham (United States) founded in 2009. Cell Microsystems has raised $19.1 million across 23 funding rounds from investors including NIH, HHS and NCBiotech. Cell Microsystems has completed 1 acquisition, including Fluxion Biosciences. Cell Microsystems operates in a competitive market with competitors including NanoCellect Biomedical, ThinkCyte, Silicon Biosystems, Cytena and Singulex, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19.1 M (USD)
in 23 rounds
-
Latest Funding Round
$6.5 M (USD), Series B
Aug 23, 2023
-
Investors
NIH
& 5 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Cell Microsystems
Unlock access to complete
Unlock access to complete
Funding Insights of Cell Microsystems
Cell Microsystems has successfully raised a total of $19.1M across 23 strategic funding rounds. The most recent funding activity was a Series B round of $6.5 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cell Microsystems
Cell Microsystems has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and NCBiotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Biotech startups are incubated and funded in North Carolina.
|
Locked | Locked | Locked |
Investor details for Cell Microsystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cell Microsystems
Cell Microsystems has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fluxion Biosciences.
Investment portfolio details for Cell Microsystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microfluidics-based tools for cellular analysis are provided.
|
Locked | Locked | 2005 | Locked |
Complete acquisition details for Cell Microsystems
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cell Microsystems
Detailed financials for Cell Microsystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cell Microsystems Comparisons
Peer comparison for Cell Microsystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cell Microsystems
Cell Microsystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, ThinkCyte, Silicon Biosystems, Cytena and Singulex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops flow cytometry and cell sorting technology
|
|
| Locked | Locked | Locked |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| Locked | Locked | Locked |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| Locked | Locked | Locked |
Single cells are isolated using the cy-Clone device technology.
|
|
| Locked | Locked | Locked |
Single-molecule counting technology is developed for cardiovascular biomarker detection.
|
Detailed competitors of Cell Microsystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cell Microsystems
Complete news archive for Cell Microsystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cell Microsystems
Cell Microsystems was founded in 2009.
Cell Microsystems is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Cell Microsystems is a funded company, having raised a total of $19.1M across 23 funding rounds to date.
Cell Microsystems was founded in 2009 in Durham, United States, within the biotechnology sector. A proprietary technology is developed to isolate and recover single cells for molecular analysis. The CellRaft AIR system is utilized to track cells, accelerate colony growth, and enable gentle sorting and isolation processes. Operations focus on advancing cell-based research tools for scientific applications.
Cell Microsystems's top competitors include NanoCellect Biomedical, ThinkCyte and Silicon Biosystems.
Cell Microsystems has made 1 acquisition, including Fluxion Biosciences.
Cell Microsystems has 6 investors. Key investors include NIH, HHS, NCBiotech, Telegraph Hill Partners, and Telegraph Hill Partners.